Clinical trial
Bioavailability and Metabolism of Voriconazole as a Function of the CYP2C19 Genotype
NCT00175994 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioavailability and Metabolism of Voriconazole as a Function of the CYP2C19 Genotype
- Lead sponsor
- Heidelberg University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- July 31, 2006
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy